Pharm Exec’s latest report covers the significant transformations taking place in the global biopharma industry, with the trajectory of commercial output and product direction taking centre stage. In this blog, we will explore the key trends and factors shaping the industry’s future, including the impact of non-pandemic treatment trends, market drivers, and other macroeconomic factors. We will also delve into the implications of mergers and acquisitions (M&A) and the ongoing challenges posed by the COVID-19 pandemic.